Anne Lewin
- Developmental Neuroscience top 2%
- Cancer Research top 5%
- NF-κB Signaling Pathways 3
- Oncology top 5%
- Cancer-related Molecular Pathways 2
- Immunology top 5%
- Immune Response and Inflammation 3
-
- Angiogenesis and VEGF in Cancer 5
- Fibroblast Growth Factor Research 3
- Hedgehog Signaling Pathway Studies 2
-
- Cell Adhesion Molecules Research 3
-
- Microtubule and mitosis dynamics 2
Anne Lewin
27 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Developmental Neuroscience 277
- Cancer Research 601
- Cellular and Molecular Neuroscience 715
- Oncology 894
- Immunology 524
Countries citing papers authored by Anne Lewin
This map shows the geographic impact of Anne Lewin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Lewin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Lewin more than expected).
Fields of papers citing papers by Anne Lewin
This network shows the impact of papers produced by Anne Lewin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Lewin. The network helps show where Anne Lewin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anne Lewin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 23 | |
| 2 | 2015 | 72 | |
| 3 | 2014 | 4 | |
| 4 | 2011 | 18 | |
| 5 | 2010 | 52 | |
| 6 | 2008 | 37 | |
| 7 | Assessment of tissue biomarkers following anti-CD137 treatment in the EMT-6 mouse tumor model. | 2006 | 2 |
| 8 | Preclinical studies of BMS-582664, an alanine prodrug of BMS-540215, a potent, dual inhibitor of VEGFR-2 and FGFR-1 kinases | 2005 | 1 |
| 9 | 2005 | 37 | |
| 10 | 1998 | 57 | |
| 11 | Osteopetrosis in mice lacking NF-κB1 and NF-κB2breakdown → | 1997 | 840 |
| 12 | 1997 | 13 | |
| 13 | 1995 | 27 | |
| 14 | 1995 | 172 | |
| 15 | 1994 | 103 | |
| 16 | Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor genebreakdown → | 1994 | 792 |
| 17 | 1991 | 17 | |
| 18 | 1991 | 4 | |
| 19 | 1991 | 30 | |
| 20 | 1988 | 77 |
About Anne Lewin
Anne Lewin is a scholar working on Immunology and Allergy, Cancer Research, Sensory Systems, Oncology and Immunology, having authored 27 papers that have together received 2.9k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (5 papers), Fibroblast Growth Factor Research (3 papers), Immune Response and Inflammation (3 papers), Cell Adhesion Molecules Research (3 papers), NF-κB Signaling Pathways (3 papers), Cancer-related Molecular Pathways (2 papers), Hedgehog Signaling Pathway Studies (2 papers) and Microtubule and mitosis dynamics (2 papers). The work is most often cited by research in Developmental Neuroscience (277 citations), Cancer Research (601 citations), Cellular and Molecular Neuroscience (715 citations), Oncology (894 citations) and Immunology (524 citations). Anne Lewin has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Sérgio A. Lira, Rodrigo Bravo, Yi Yang, Violetta Iotsova, James Loy, Jorge Caamaño, Richard J. Smeyne, Andreas Schnapp, Mariano Barbacid and Rüdiger Klein. Their work appears in journals such as Cancer Research, Inflammation Research, Molecular Cancer Therapeutics, The Journal of Experimental Medicine and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.